Egalet

company

About

Egalet is a specialty pharmaceutical company that develops pain management products.

  • 51 - 100

Details

Last Funding Type
Series B
Last Funding Money Raised
$27.60M
Industries
Biopharma,Biotechnology,Health Care
Founded date
Jan 1, 1995
Number Of Employee
51 - 100
Operating Status
Active

Egalet is a specialty pharmaceutical company that develops pain management products. The company is developing a pipeline of abuse-resistant opioids that are nearing pivotal testing. Egalet has pioneered one of the world’s first erosion-based delivery technologies to enable the controlled release of drugs through gradual erosion of a tablet and has optimized the abuse deterrent properties that can be applied to a broad range of opioids and non-opioids.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
$27.60M
Egalet has raised a total of $27.60M in funding over 2 rounds. Their latest funding was raised on Apr 2, 2007 from a Series B round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Apr 2, 2007 Series B $27.60M 1 Detail

Investors

Number of Lead Investors
Number of Investors
1
Egalet is funded by 1 investors. Biofund are the most recent investors.
Investor Name Lead Investor Funding Round
Biofund Series B